📜7-氯-6-氟-4-氧代-1,4-二氢喹啉-3-羧酸乙酯置于sodium Hydroxide,乙酸酐,Potassium Carbonate,2,4-二硝基苯基羟胺体系中,用 吡啶,水,N,N-二甲基甲酰胺 作为反应溶剂,化学反应 22.0H,反应生成 氨氟沙星 参考文献:Novel Amino-Substituted 3-Quinolinecarboxylic Acid Antibacterial Agents: Synthesis And Structure-Activity Relationships 标题:Novel Amino-Substituted 3-Quinolinecarboxylic Acid Antibacterial Agents: Synthesis And Structure-Activity Relationships 摘要:A Series Of Novel 3-Quinolinecarboxylic Acid Derivatives Have Been Prepared And Their Antibacterial Activity Evaluated. These Derivatives Are Characterized By Fluorine Attached To The 6-Position And Substituted Amino Groups Appended To The 1-And 7-Positions. Structure-Activity Relationship Studies Indicate That Antibacterial Potency Is Greatest When The 1-Substituent Is Methylamino And The 7-Substituent Is Either 4-Methyl-1-Piperazinyl,16,Or 1-Piperazinyl,21. Derivatives 16 And 21,The 1-Methylamino Analogues Of Pefloxacin And Norfloxacin,Respectively,Show Comparable In Vitro And In Vivo Antibacterial Potency To These Two Known Agents. The Activity (Vs. Escherichia Coli Vogel) Of 16 (Amifloxacin) Is The Following: In Vitro Mic (Microgram/ml) = 0.25; In Vivo (Mice) Pd50 (Mg/kg) = 1.0 (Po),0.6 (Sc). DOI:10.1021/jm00375A003
专利号:US-8093381-B2 优先权日:2007-05-24 标题:Method of synthesis of fluoroquinolones 发明人:BERTHON-CEDILLE LAURENCE; LEGUERN MARIE-EMMANUELLE; RENAUD GILLES; TOMBRET FRANCIS 权利人:BERTHON-CEDILLE LAURENCE; LEGUERN MARIE-EMMANUELLE; RENAUD GILLES; TOMBRET FRANCIS; BIOCODEX 摘要:The invention relates to a method of preparation of fluoroquinolones of formula (I) from compounds of formula (II): n nin which R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and X are as defined in Claim 1.
专利号:US-9693999-B2 优先权日:2011-01-26 标题:Small molecule RNase inhibitors and methods of use 发明人:DUNMAN PAUL M; OLSON PATRICK D; CHILDERS WAYNE 权利人:UNIV ROCHESTER; UNIV NEBRASKA; Temple University—Of the Commonwealth System of Higher Education 摘要:Small molecule inhibitors of bacterial ribonuclease (e.g., RnpA) and methods for their synthesis and use are described herein. The methods of using the compounds include treating and preventing microbial infections and inhibiting bacterial ribonuclease. Also described herein are methods of identifying compounds for treating or preventing a microbial infection.
专利号:WO-2009056955-A1 优先权日:2007-10-30 标题 :Amine-bearing phospholipids (abps), their synthesis and use 发明人:ZUMBUEHL ANDREAS 权利人:UNIV BASEL; ZUMBUEHL ANDREAS 摘要:Disclosed herein are amine-bearing phospholipids (ABP). The ABPs display many properties and functionalities of naturally occurring phospholipids, but also new properties and functionalities, such as the ability to polymerize while maintaining structural integrity, that may supplement or expand the functionalities of naturally occurring phospholipids.
专利号:US-9868747-B2 优先权日:2014-02-18 标题:Marinopyrrole derivatives and methods of making and using same 发明人:LI RONGSHI; SEBTI SAID; LIU YAN; QIN YONG; SONG HAO; CHENG CHUNWEI 权利人:H LEE MOFFITT CANCER CT & RES; CHONGQING ZEIN PHARMACEUTICAL CO LTD 摘要:Marinopyrrole derivatives and methods for their synthesis and use are described herein. Novel cyclic and symmetric marinopyrroles with triazole substituents having antibacterial activity against resistant bacterial strains, such as MRSA are introduced. Also provided are methods of using the compounds for treating or preventing cancer and/or microbial infections.
专利号:US-2009054643-A1 优先权日:2007-05-24 标 题:Novel method of synthesis of fluoroquinolones
专利号:US-9907753-B2 优先权日:2010-03-19 标 题 :Lipid vesicle compositions and methods of use 发明人:IRVINE DARRELL J; MOON JAEHYUN 权利人:MASSACHUSETTS INST TECHNOLOGY 摘要:The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles may comprise prophylactic, therapeutic and/or diagnostic agents.
1: Venezia RA, Prymas LA, Shayegani A, Yocum DM. In vitro activities of amifloxacin and two of its metabolites. Antimicrob Agents Chemother. 1989 May;33(5):762-6. 2: Iravani A, Welty GS, Newton BR, Richard GA. Effects of changes in pH, medium, and inoculum size on the in vitro activity of amifloxacin against urinary isolates of Staphylococcus saprophyticus and Escherichia coli. Antimicrob Agents Chemother. 1985 Apr;27(4):449-51.
合成参考文献
参考文献:10.1021/jm030986y 摘要:Cianchetta G, Mannhold R, Cruciani G, Baroni M, Cecchetti V. Chemometric studies on the bactericidal activity of quinolones via an extended VolSurf approach. J Med Chem. 2004 Jun 03;47(12):3193–201. doi: 10.1021/jm030986y. 参考文献:10.1021/jm00153a015 摘要:Domagala JM, Hanna LD, Heifetz CL, Hutt MP, Mich TF, Sanchez JP, Solomon M. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay. J Med Chem. 1986 Mar;29(3):394–404. doi: 10.1021/jm00153a015. 参考文献:10.1021/jm00154a003 摘要:Domagala JM, Heifetz CL, Mich TF, Nichols JB. 1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid. New quinolone antibacterial with potent gram-positive activity. J Med Chem. 1986 Apr;29(4):445–8. doi: 10.1021/jm00154a003. 参考文献:10.1007/bf02013968 摘要:Høiby N. Clinical uses of nalidixic acid analogues: the fluoroquinolones. European Journal of Clinical Microbiology & Infectious Diseases. 1986 Apr;5(2):138–40. doi: 10.1007/bf02013968. 参考文献:10.1016/0163-7258(85)90005-1 摘要:Diana GD, Otto MJ, McKinlay MA. Inhibitors of picornavirus uncoating as antiviral agents. Pharmacology & Therapeutics. 1985 Jan;29(3):287–97. doi: 10.1016/0163-7258(85)90005-1.